Navigation Links
TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement
Date:4/1/2008

TechTeam Global's shared e-clinical service desk expands support to another

leading pharmaceutical company

SOUTHFIELD, Mich., April 1, 2008 /PRNewswire-FirstCall/ -- TechTeam Global, Inc. (Nasdaq: TEAM), a worldwide provider of information technology (IT), enterprise support and business process outsourcing services, today announced that its subsidiary, TechTeam Global nv/sa, has been selected by sanofi-aventis recherche & developpement (research & development) to provide help desk and site provisioning services to sanofi-aventis clinical trial investigators around the world.

TechTeam is a leading provider of e-clinical support services that help pharmaceutical companies, which are involved in clinical trials on a global basis, to optimize Electronic Data Capture ("EDC") and accelerate time-to- market for testing new drugs. TechTeam will support sanofi-aventis on multiple studies over approximately 50 countries across the globe. TechTeam will be providing e-clinical support services, including site assessments, hardware deployments and help desk services in over 20 languages.

"Making sure that investigators are supported in the best possible way is crucial in making an e-clinical trial a success. TechTeam was chosen by sanofi-aventis to provide quality-driven customer service support, in combination with technical and procedural support, in order to facilitate the investigators' participation in the e-clinical studies," observes Florence Berger, sanofi-aventis' Clinical Operations, Global Head, Monitoring Systems & Data Flow.

TechTeam's experience providing global EDC support services, a proven track record in supporting large pharmaceutical clinical trials, and sophisticated yet flexible delivery capabilities were the main factors influencing sanofi-aventis' decision.

"We are pleased to be providing sanofi-aventis recherche & developpement with a solution that will maximize clinical trial efficiency," said Christoph Neut, TechTeam's Senior Vice President for Europe. "Based on our focused efforts to build a world-class global EDC help desk support platform, TechTeam has been successful in adding several new multilingual EDC support programs to its portfolio over the last five years. This new relationship with sanofi- aventis demonstrates again that TechTeam's capabilities are acknowledged by leading pharmaceutical and health care companies around the world."

About TechTeam Global, Inc.

TechTeam Global, Inc. is a worldwide provider of information technology, enterprise support and business process outsourcing services to Fortune 1000 corporations, multinational companies, product providers, small and medium- sized companies, and government entities. TechTeam's ability to integrate computer services into a flexible, ITIL-based solution is a key element of its strategy. Partnerships with some of the world's "best-in-class" corporations provide TechTeam with unique expertise and experience in providing information technology support solutions. For information about TechTeam Global, Inc. and its services, call 800-522-4451 from the United States or visit our Web sites at http://www.techteam.com and http://www.techteam.eu. TechTeam's common stock is traded on the Nasdaq Global Market under the symbol "TEAM."

Safe Harbor Statement

The statements contained in this press release that are not purely historical, including statements regarding the Company's expectations, hopes, beliefs, intentions or strategies regarding the future, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding, among other things, the Company's performance going forward. Forward-looking statements may be identified by words including, but not limited to, "anticipates," "believes," "intends," "estimates," "promises," "expects," "should," "conditioned upon," and similar expressions. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Such factors include, but are not limited to, delays in the implementation of the service model, the inability of TechTeam to staff the project with sufficient qualified resources, changes in the customer's business or the requirements thereof, unanticipated problems that arise from the transition from the customer's former service provider, and other difficulties in providing the service solutions for the customer. All forward- looking statements included in this press release are based on information available to the Company on the date hereof, and the Company assumes no obligation to update any such forward-looking statements. Prospective investors should also review the Company's Reports on Forms 8-K, 10-Q and 10-K filed with the United States Securities and Exchange Commission, including Management's Discussion and Analysis of Financial Condition and Results of Operations, and the risks described therein from time to time.


'/>"/>
SOURCE TechTeam Global, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Super-Sod will attend ... 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show ... , For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Social media ... especially for hospitals and health systems. Smith & Jones’ delves into this insight and ... episode, President of Smith & Jones David Vener meets up with social media strategist ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a ... Medical University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, ... on Aging is a tremendous resource in our community. We are thrilled to participate ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced that KCP-400 (RgIA4), a potent antagonist ... robust chronic pain relief and disease modifying effects ... the a9a10 nAChR as a new, non-opioid target ... were reported online in the February 20 th ...
Breaking Medicine Technology: